ZBH
ZIMMER BIOMET HOLDINGS, INC.
NYSE · Healthcare · Medical - Devices · US
$95.36
+1.18%Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$94.04
From 52W high−8.29%
Volume3.76M
Market cap$18.19B
P/E (TTM)23.1x
P/S (TTM)2.1x
Div yield0.50%
Key dataSep 18, 2026
Open
$94.04
From 52W high
−8.29%
Volume
3.76M
Market cap
$18.19B
ValuationView details →
P/E (Fwd)
10.9x
EV/EBITDA
12.9x
P/E (TTM)
23.1x
RSI (14)
46.3
MomentumView details →
1D Return
+1.18%
YTD Return
+5.89%
SummaryUpdated Jun 1, 2026
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) is a leading global medical device company specializing in musculoskeletal healthcare solutions. Founded in 1927 and headquartered in Warsaw, Indiana, the company emerged from the merger of Zimmer Holdings and Biomet in 2015. Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive products, surgical instruments, and related technologies used to treat patients with bone, joint, and soft tissue disorders or injuries.
Similar companies
Latest newsMore news →
In August 2026, the second-instance ruling in the contract dispute between Guoke Hengtai's wholly-owned subsidiary Guoke Hengmao and Zimmer Biomet and Jiemei Medical dismissed the appeal and upheld the original judgment.4d agoZimmer Biomet announced that Kevin Thornal will depart as Group President of Global Businesses and the Americas, effective September 30, 2026, with severance of twelve months' salary and bonus plus COBRA premiums.12d agoZimmer Biomet announced leadership promotions in its Americas commercial organization, promoting Gary Campbell to President, Americas; Brian Hatcher to President, Recon, S.E.T., CMFT, Neuro and Biosurgery; and Bradley Kessler to President, Americas – Robotics, Technology and Data.12d ago